“Dupilumab Improves Symptoms and Quality of Life in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: RELIEVE-AD-PED Study”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s737. https://doi.org/10.25251/0y59xj91.